Companies: 10,795·Total market cap: $144.5T
HUTCHMED (China) Limited

HUTCHMED (China) Limited

HMDCFOTCHealthcare● Active
$2.90
+$0.74(+34.26%)
Market Cap$2.5B
P/E Ratio
52W High$3.815
52W Low$2.16

HUTCHMED (China) Limited (HMDCF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

HMDCF · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.37B +63.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$71.3M
cashAndCashEquivalents
Short-Term Investments
$1.30B
shortTermInvestments
YoY Change vs Prior Year
+63.5%
vs prior fiscal year
Latest Quarter
$1.37B
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$1.37BCash on Hand
Total Debt$97.9MTotal Debt
Net Cash / Net Debt+$1.27BNet Cash Position
Cash vs Debt Ratio
Cash 93%Debt 7%

HUTCHMED (China) Limited has a net cash position of $1.27B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.37B$97.9M = +$1.27B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
HMDCF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$1.37B+63.5%
Dec 31, 2024$836.1M-5.7%
Dec 31, 2023$886.3M+40.5%
Dec 31, 2022$631.0M-37.6%
Dec 31, 2021$1.01B+132.5%
HMDCF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
HUTCHMED (China) Limited
HUTCHMED (China) LimitedYOU
HMDCF
$1.37B54.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

HUTCHMED (China) Limited (HMDCF) cash on hand as of December 31, 2025 is $1.37B, comprising $71.3M in cash and cash equivalents (CCE) plus $1.30B in short-term investments — reported as HUTCHMED (China) Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as HUTCHMED (China) Limited cash reserves or cash position.

HUTCHMED (China) Limited annual cash on hand history shows increased +63.5% in 2025: increased +63.5% in 2025. HUTCHMED (China) Limited cash reserves in 2025 reflect the company's capital allocation strategy.

HUTCHMED (China) Limited carries total debt of $97.9M against cash of $1.37B, resulting in a net cash position of +$1.27B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

HMDCF cash on hand · 5 questions

As of December 31, 2025, HUTCHMED (China) Limited (HMDCF) has $1.37B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $71,320,613 in cash and cash equivalents (CCE) plus $1.30B in short-term investments. Latest quarter (December 31, 2025): $1.37B. Data sourced from the annual 10-K filing via FMP.

HMDCF cash on handHMDCF cash reservesHMDCF cash 2025how much cash does HMDCF have

Source: FMP /balance-sheet-statement · US GAAP · HUTCHMED (China) Limited · HUTCHMED (China) Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025